Objective To investigate the clinical effect of repaglinide tablets+metformin tablets in patients with type 2 diabetes mellitus.Methods The clinical data of 80 patients with type 2 diabetes mellitus admitted to Guangzhou University of Chinese Medicine Shenzhen Hospital(Fution)from January 2023 to January 2024 were retrospectively selected and divided into two groups according to different treatment methods,with 40 cases in each group.The refer-ence group was treated with repaglinide tablets.On the basis of the reference group,the study group selected metfor-min tablets for treatment.The total effective rate of drug treatment and the control effect of blood glucose level(fasting plasma glucose and 2-hour postprandial plasma glucose)were compared between the two groups.Results The total ef-fective rate of treatment in the study group was higher than that in the reference group,and the difference was statisti-cally significant(P<0.05).Before treatment,there was no statistically significant difference in the blood glucose levels between the two groups(both P>0.05).After treatment,the blood glucose levels of the study group were lower than those of the reference group,and the differences were statistically significant(both P<0.05).Conclusion The combina-tion therapy of repaglinide tablets and metformin tablets in type 2 diabetes mellitus can improve the therapeutic effect and improve the control effect of blood glucose level.
Type 2 diabetes mellitusGeneral outpatient treatmentRepaglinide tabletsMetformin tabletsBlood glucose level
NETL
NSTL
万方数据
